Children and Young People with Type 1 Diabetes: What Actually Matters Most

One body, four rhythms

The body talks back through the glucose, honestly, in every age band. What shifts is what the family is doing, and what the child can do for themselves. The international paediatric guidelines (ISPAD 2024) now route care through four bands: infant under 2, preschool 2 to 6, paediatric 7 to 14, and adolescent 15 to 17. Each band has its own rhythm, its own evidence layer, and its own moments that the family already knows by heart.

Under 2: when the body cannot yet speak

You learn the signs your child cannot tell you. The way the mood drops before the number does. The half-second pause before a feed. The damp cot at 4am that means you missed something three hours ago. Most of the under-2s diagnosed with T1D arrive in DKA, around sixty percent of children diagnosed under their first birthday in the largest international study we have (Cherubini 2020, Diabetologia). It is rarely because anyone missed the textbook signs. The textbook was written for older children, and infants present with vomiting, sleepiness, and faster breathing first. By the time anyone knows what they are looking at, the child is already in trouble.

After the first admission, the work is largely yours. The dose is small enough that a 0.1-unit error matters. The child cannot tell you they feel low. The CGM line at 4am becomes the closest thing to a voice they have. In children aged 1 to 7, two trials have shifted what is possible. KidsAP02 (Ware 2022, NEJM) showed hybrid closed-loop with CamAPS FX took nighttime time-in-range to eighty-two percent without raising hypoglycaemia. The Omnipod 5 preschool trial (Sherr 2022) ran the same direction in two- to five-year-olds: more time in range, no severe hypos, no DKA across thirteen weeks. The systems do not remove the work. They shift where the work goes. You watch fewer numbers, you trust the algorithm overnight, and you reclaim some of the sleep you have lost.

None of this is easy to start, and access varies. Your paediatric diabetes team is the first conversation. Ask early, ask in writing if you need to, and ask again if the first answer is “not yet”.

Two to six: the toddler who tells you everything except their glucose

Toddlers tell you everything. They tell you they are tired, hungry, bored, scared, brilliant, furious. They do not yet tell you they are 3.4 mmol/L (61 mg/dL) and dropping. The energy crash before lunch, the unprovoked tears at 4pm, the strange quiet ten minutes into the playground; these are the family’s translation system, and the family is the one decoding them. By the time a child is three or four, parents and grandparents and nursery staff have built up an instinct that no algorithm has, and the algorithm gets better when it learns from them.

The evidence base in this band has matured in the last three years. The Omnipod 5 preschool trial (Sherr 2022, Diabetes Care) showed time in range up by around eleven percentage points, roughly two and a half extra hours a day in target, with no severe hypoglycaemia and no DKA. KidsAP02 (Ware 2022) ran in the same direction with CamAPS FX, with the heaviest benefit overnight. ISPAD 2024 Chapter 23 now recommends hybrid closed-loop in this age band where it is available. There is one finding from the older evidence that AID has changed: in the open-loop pump era, Karges 2017 showed the severe-hypoglycaemia advantage of pumps over injections did not extend to one and a half to five year olds. Closed-loop is the technology that finally closed that gap.

Where the work changes shape is the second site of care. Nursery, grandparents, the babysitter on a Friday evening, the swim teacher. Every site needs a plan, a CGM-share permission, a glucagon rescue kit (nasal glucagon is licensed from age four and is materially easier for a non-clinician to deliver in a real emergency), and one clear point of contact. Most paediatric diabetes teams will help you write the school or nursery plan if you ask. Ask your team for it; ask them to put it in writing; ask them to update it when the child moves between settings.

Seven to fourteen: the child who is starting to manage their own diabetes

The school morning is the moment. Sandwich box, PE kit, glucose tabs in the side pocket, CGM check, “have you got everything?”, and the door. Some days the child is in charge of the whole sequence; some days they are five years old in a fourteen-year-old body and need every step done for them. This is the band where the cognitive partnership starts. The child is learning to read their own body, the parent is learning when to step in and when to step back, and the diabetes team is learning what kind of family this is.

The trial evidence in this band is the deepest of any paediatric age group. The MiniMed 780G paediatric pivotal (Pihoker 2023, Diabetes Technology and Therapeutics) and the Omnipod 5 pivotal (Brown 2021) both show sustained time-in-range gains. Bassi 2023 ran a small Italian retrospective head-to-head between MiniMed 780G and Tandem Control-IQ; the MiniMed group sat at seventy-one percent time-in-range against the Tandem group’s sixty-eight, but the groups differed materially in age and starting HbA1c, so the read is direction not verdict. The system that fits this child’s life and this family’s preference is the one that delivers the most. ISPAD 2024 chapters 16, 17, and 22 cover technology and the school day; the structured-education programmes (DAFNE for older adolescents and young adults, BERTIE-online, the BWC DYNAMIC and GAME programmes) are the curriculum we lean on for the carbohydrate-counting and bolus-timing layer.

One leading indicator we now watch carefully is quality of life. Hilliard 2013 (Patient Education and Counseling) followed adolescents over twelve months and showed that lower quality of life at the start of a care year predicted reduced blood-glucose monitoring at six months, which then predicted higher HbA1c at twelve. Quality of life is not a soft endpoint here; it is upstream of the behaviour that drives the trajectory. ISPAD 2024 Chapter 15 treats screening for diabetes distress, depressive symptoms, and family functioning as part of the routine diabetes visit, not a referral out. If something has changed in your child’s mood, sleep, eating, or engagement with diabetes care, your team is the first conversation. They have the brief script, they know who to bring in, and they would rather hear it early.

Fifteen to seventeen: the late teenager standing on the bridge to adult care

The exams matter. The friendships matter. The first job and the first long evening at someone else’s house matter. Through all of it, the diabetes is still there at 4pm and 11pm and 3am, whether the teenager wants it to be or not. This is the bridge to adult care, and the international data tell us it is the canonical glycaemic dip; the teenager has more on their plate than at any point so far, and the diabetes is asking for the same attention as ever.

The Karges 2024 DPV cohort (Lancet Diabetes Endocrinology) is the trial to know. In nearly fourteen thousand young people on closed-loop, DKA risk concentrates in those whose HbA1c sits above 7.5 percent, and rises further above 8.5 percent. The mechanism is plain enough: when the algorithm is doing the day-to-day work, device problems and missed insulin go undetected for longer. The educational response is sick-day rules, ketone monitoring, and a routine of looking at the system together every few weeks. The broader response is a mental-health and identity conversation that has to happen alongside the technology, not after it.

The validated instrument for this window is the Problem Areas in Diabetes, Emerging Adult version (Wentzell 2022). It captures what late-teen and emerging-adult distress actually looks like: cost worries, perfectionism, future-children worries, partner-disclosure worries, feeling judged by people who do not have T1D. ISPAD 2024 chapters 15 and 21 treat routine screening for distress, depressive symptoms, and disordered eating as part of the diabetes visit. Eating-disorder risk in T1D is higher than in the general population, and the early signs (insulin omission, unexplained weight change, hidden meal patterns) are the team’s job to look for. Telling the team early is not over-reacting; it is exactly what the team is there for.

The bridge to adult care begins now, not at the moment of the actual transition. Most paediatric services start the conversation eighteen months out, write a transition plan with the young person in the room, and join the first adult clinic appointment if asked. The young person, the family, and the diabetes team are all on this bridge together; the team’s job is to make sure no one steps off it alone.

The four pivotal trials, side by side

Across the four bands, the closed-loop trials run in the same direction. The picture below puts them next to each other so the family lens reads cleanly: the gain is real, the magnitude is similar, the populations and durations differ, and a head-to-head between systems is not what these trials were built to be.

What carries across all four bands

If you are reading this with a child on a CGM in the next room, the thread that joins the four bands is something you already know. The family is the constant. Not in a sentimental way; in a clinical and structural way. The CGM share goes to the parent, then to the parent and the partner, then to the parent and the school, then to the young person and a slowly-receding parent. The sibling without T1D absorbs the family rhythm anyway. The partner of a parent with a child with T1D learns the night-time language even before they learn the daytime one. The diabetes team is the second constant; they hold the longitudinal record across the bands, they know what your family does well and where it tends to struggle, and they are the people best placed to spot the moments where the routing changes.

Population averages are most of the story. They are not all of it. The trials we lean on describe what happens to the typical child and the typical family; the technology, the structured education, and the team-and-family partnership get most families most of the way to the gain. The remaining piece is your child, and it is where life actually happens. Every figure on this page is a starting point for a conversation with your diabetes team, not a target to hit alone.

References